{
  "docId": "019de073-9523-714b-a2b4-ffafcdbd0ef0",
  "docSlug": "bc9bef6f52d4d9603180b6eb6c4f9d10",
  "documentTitle": "SAB Biotherapeutics | Results Presentation Deck | 12 slides",
  "authorId": "sab-biotherapeutics",
  "authorName": "SAB Biotherapeutics",
  "documentKindSlug": "regulatory-filing",
  "documentKindLabel": "Regulatory filing",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 12,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide presents two line charts comparing treatment and placebo groups over time relative to viral challenge.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9523-714b-a2b4-ffafcdbd0ef0/9",
  "deckHref": "/decks/019de073-9523-714b-a2b4-ffafcdbd0ef0",
  "deckJsonHref": "/decks/019de073-9523-714b-a2b4-ffafcdbd0ef0.json",
  "deckAnchorHref": "/decks/019de073-9523-714b-a2b4-ffafcdbd0ef0#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.38,
        "x": 0.08,
        "y": 0.28
      },
      "kind": "callout",
      "text": "Achieved Statistically Significant (p = 0.026) Reduction in Viral Load",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c43ceb7-557f-4a95-b38d-d3a944f4589b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.42,
        "x": 0.52,
        "y": 0.28
      },
      "kind": "callout",
      "text": "SAB-176 Achieved Statistically Significant (p = 0.013) Improvement in Symptomology at Day 4",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e441f4cd-0200-4021-9681-8d7bb3d5122f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Mean Viral Load by Nasal Samples qRT-qPCR by Day Relative to Viral Challenge",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae3a3b40-0a30-4e99-9f7b-e9278e91d769",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.52,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Mean Total Symptom Score by Day Relative to Viral Challenge",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8141004-bc64-4547-816c-ddaede46065c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "© 2022 SAB BIOTHERAPEUTICS, INC.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2486b9fd-472e-406a-8217-1b9cc93c252a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.65,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "SAB-176 Met the Primary Endpoint of Viral Load and Secondary Endpoint of Symptom Reduction",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c71c988f-185e-4bcc-a7f3-ae573ee3fb0b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chartjunk Elimination",
      "slug": "chartjunk-elimination",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "a23be2bc-8944-4689-8b55-d185b983a410",
      "evidence": "Mean Viral Load by Nasal Samples qRT-qPCR by Day Relative to Viral Challenge",
      "confidence": 0.7
    },
    {
      "name": "Data-Ink Ratio",
      "slug": "data-ink-ratio",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "d66c5cb1-7361-42f4-b283-c76cf8155751",
      "evidence": "Mean Viral Load by Nasal Samples qRT-qPCR by Day Relative to Viral Challenge",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}